Age-related differences in olfactory training outcomes: A prospective cohort study.
SNOT‐22
olfactory disorders
olfactory test
Journal
International forum of allergy & rhinology
ISSN: 2042-6984
Titre abrégé: Int Forum Allergy Rhinol
Pays: United States
ID NLM: 101550261
Informations de publication
Date de publication:
12 Sep 2024
12 Sep 2024
Historique:
revised:
01
09
2024
received:
28
03
2024
accepted:
03
09
2024
medline:
12
9
2024
pubmed:
12
9
2024
entrez:
12
9
2024
Statut:
aheadofprint
Résumé
While olfactory function decreases with age, it is unknown how age affects olfactory training (OT) efficacy. This study compared OT in two cohorts of subjects: aged ≤50 (younger cohort) and aged 51+ (older cohort) with olfactory dysfunction (OD) primarily from COVID-19 infection. Subjects with OD primarily secondary to COVID-19 infection were prospectively recruited and enrolled into an OT registry. Baseline data were collected and they were provided with a training kit and asked to complete OT at home twice daily for 6 months. Participants were asked to follow-up at 3 and 6 months during training for olfactory testing and quality-of-life surveys (Sino-Nasal Outcomes Test-22 [SNOT-22] and Questionnaire of Olfactory Disorders Negative Statements [QoD-NS]). Fifty-six participants completed OT (younger cohort: n = 26, older cohort: n = 30). There were no significant differences between cohorts' Affordable Rapid Olfactory Measurement Array (AROMA), QoD-NS, or SNOT-22 scores at any time point. Both cohorts showed significant AROMA score improvement of more than 16 points from baseline to 3 months (younger cohort: p = 0.001; older cohort: p = 0.008). The younger cohort had significant improvements in QoD-NS (p = 0.008) and SNOT-22 (p = 0.042) between baseline and 3 months while the older cohort improved from 3 to 6 months (QoD-NS: p = 0.027, SNOT-22: p = 0.049). Both cohorts demonstrated similar significant improvement in olfactory function after 3 months of OT. The timeline of subjective improvement was different between cohorts, with younger patients experiencing earlier improvement.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 ARS‐AAOA, LLC.
Références
Bianchi AJ, Guépet‐Sordet H, Manckoundia P. Changes in olfaction during ageing and in certain neurodegenerative diseases: up‐to‐date. Rev Med Internet. 2015;36(1):31‐37. doi:10.1016/j.revmed.2014.09.008
Hummel T, Liu DT, Müller CA, Stuck BA, Welge‐Lüssen A, Hähner A. Olfactory dysfunction: etiology, diagnosis, and treatment. Dtsch Arztebl Int. 2023;120(9):146‐154. doi:10.3238/arztebl.m2022.0411
Boyce JM, Shone GR. Effects of ageing on smell and taste. Postgrad Med J. 2006;82(966):239‐241. doi:10.1136/pgmj.2005.039453
Olofsson JK, Ekström I, Larsson M, Nordin S. Olfaction and aging: a review of the current state of research and future directions. Iperception. 2021;12(3):20416695211020332. doi:10.1177/20416695211020331
Vandersteen C, Payne M, Dumas LÉ, et al. Olfactory training in post‐COVID‐19 persistent olfactory disorders: value normalization for threshold but not identification. J Clin Med. 2022;11(12):3275. doi:10.3390/jcm11123275
Pekala K, Chandra RK, Turner JH. Efficacy of olfactory training in patients with olfactory loss: a systematic review and meta‐analysis. Int Forum Allergy Rhinol. 2016;6(3):299‐307. doi:10.1002/alr.21669
Kronenbuerger M, Pilgramm M. Olfactory training. StatPearls. StatPearls Publishing; 2024. Accessed April 20, 2024. http://www.ncbi.nlm.nih.gov/books/NBK567741/
Kollndorfer K, Fischmeister FPS, Kowalczyk K, et al. Olfactory training induces changes in regional functional connectivity in patients with long‐term smell loss. Neuroimage Clin. 2015;9:401‐410. doi:10.1016/j.nicl.2015.09.004
Kollndorfer K, Kowalczyk K, Hoche E, et al. Recovery of olfactory function induces neuroplasticity effects in patients with smell loss. Neural Plast. 2014;2014:140419. doi:10.1155/2014/140419
Coelho DH, Reiter ER, Budd SG, Shin Y, Kons ZA, Costanzo RM. Predictors of smell recovery in a nationwide prospective cohort of patients with COVID‐19. Am J Otolaryngol. 2022;43(1):103239. doi:10.1016/j.amjoto.2021.103239
Amer MA, Elsherif HS, Abdel‐Hamid AS, Elzayat S. Early recovery patterns of olfactory disorders in COVID‐19 patients; a clinical cohort study. Am J Otolaryngol. 2020;41(6):102725. doi:10.1016/j.amjoto.2020.102725
Li J, Palmer G, Shankar S, et al. Essential oil olfactory test: comparison of Affordable Rapid Olfaction Measurement Array (AROMA) to Sniffin’ Sticks 12. OTO Open. 2020;4(4):2473974×20962464. doi:10.1177/2473974X20962464
Villwock JA, Li J, Moore C, Chiu AG, Sykes KJ. Affordable Rapid Olfaction Measurement Array: a novel, essential oil‐based test strongly correlated with UPSIT and subjective outcome measures. Ann Otol Rhinol Laryngol. 2020;129(1):39‐45. doi:10.1177/0003489419870833
Mattos JL, Schlosser RJ, Mace JC, Smith TL, Soler ZM. Establishing the minimal clinically important difference for the Questionnaire of Olfactory Disorders. Int Forum Allergy Rhinol. 2018;8(9):1041‐1046. doi:10.1002/alr.22135
Phillips KM, Hoehle LP, Caradonna DS, Gray ST, Sedaghat AR. Minimal clinically important difference for the 22‐item Sinonasal Outcome Test in medically managed patients with chronic rhinosinusitis. Clin Otolaryngol. 2018;43(5):1328‐1334. doi:10.1111/coa.13177
Hummel T, Rissom K, Reden J, Hähner A, Weidenbecher M, Hüttenbrink KB. Effects of olfactory training in patients with olfactory loss. Laryngoscope. 2009;119(3):496‐499. doi:10.1002/lary.20101
Heian IT, Thorstensen WM, Myklebust TA, et al. Olfactory training in normosmic individuals: a randomised controlled trial. Rhinology. 2024;62(1):46‐54. doi:10.4193/Rhin23.229
Liu DT, Pellegrino R, Sabha M, et al. Factors associated with relevant olfactory recovery after olfactory training: a retrospective study including 601 participants. Rhinology. 2020. doi:10.4193/Rhin20.262
Fjaeldstad AW, Ovesen T, Stankevice D, Ovesen T. Olfactory training in long COVID‐19 patients with lasting symptoms including olfactory dysfunction. Dan Med J. 2023;70(3):A09220568.
Lechien JR, Vaira LA, Saussez S. Effectiveness of olfactory training in COVID‐19 patients with olfactory dysfunction: a prospective study. Eur Arch Otorhinolaryngol. 2023;280(3):1255‐1263. doi:10.1007/s00405‐022‐07665‐4
Jafar A, Lasso A, Shorr R, Hutton B, Kilty S. Olfactory recovery following infection with COVID‐19: a systematic review. PLoS One. 2021;16(11):e0259321. doi:10.1371/journal.pone.0259321
Donelli D, Antonelli M, Valussi M. Olfactory training with essential oils for patients with post‐COVID‐19 smell dysfunction: a case series. Eur J Integr Med. 2023;60:102253. doi:10.1016/j.eujim.2023.102253
Kim S, Finlay JB, Ko T, Goldstein BJ. Long‐term olfactory loss post‐COVID‐19: pathobiology and potential therapeutic strategies. World J Otorhinolaryngol Head Neck Surg. 2024;10(2):148‐155. doi:10.1002/wjo2.165
Howell J, Costanzo RM, Reiter ER. Head trauma and olfactory function. World J Otorhinolaryngol Head Neck Surg. 2018;4(1):39‐45. doi:10.1016/j.wjorl.2018.02.001
Mullol J, Mariño‐Sánchez F, Valls M, Alobid I, Marin C. The sense of smell in chronic rhinosinusitis. J Allergy Clin Immunol. 2020;145(3):773‐776. doi:10.1016/j.jaci.2020.01.024
Haehner A, Hummel T, Reichmann H. Olfactory loss in Parkinson's disease. Parkinsons Dis. 2011;2011:450939. doi:10.4061/2011/450939
Sorokowska A, Drechsler E, Karwowski M, Hummel T. Effects of olfactory training: a meta‐analysis. Rhinology. 2017;55(1):17‐26. doi:10.4193/Rhino16.195
Croy I, Nordin S, Hummel T. Olfactory disorders and quality of life–an updated review. Chem Senses. 2014;39(3):185‐194. doi:10.1093/chemse/bjt072
Mattos JL, Schlosser RJ, DeConde AS, et al. Factor analysis of the questionnaire of olfactory disorders in patients with chronic rhinosinusitis. Int Forum Allergy Rhinol. 2018;8(7):777‐782. doi:10.1002/alr.22112
Mou YK, Wang HR, Zhang WB, Zhang Y, Ren C, Song XC. Allergic rhinitis and depression: profile and proposal. Front Psychiatry. 2021;12:820497. doi:10.3389/fpsyt.2021.820497
Shetty PA, Ayari L, Madry J, Betts C, Robinson DM, Kirmani BF. The relationship between COVID‐19 and the development of depression: implications on mental health. Neurosci Insights. 2023;18:26331055231191510. doi:10.1177/26331055231191513
Zou LQ, Hummel T, Otte MS, et al. Association between olfactory function and quality of life in patients with olfactory disorders: a multicenter study in over 760 participants. Rhinology. 2021;59(2):164‐172. doi:10.4193/Rhin20.403
Amritwar AU, Lowry CA, Brenner LA, et al. Mental health in allergic rhinitis: depression and suicidal behavior. Curr Treat Options Allergy. 2017;4(1):71‐97. doi:10.1007/s40521‐017‐0110‐z